Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Dermatitis - contact - Management
What should I consider before prescribing an oral corticosteroid?

  • There is no evidence to guide the optimum dose and duration of oral corticosteroids in an acute episode of contact dermatitis. Some experts recommend prednisolone 0.5–1 mg/kg/day, given for 5–7 days and then tapered over 2–3 weeks (according to response) to prevent rebound dermatitis [Beltrani et al, 2006; Mark and Slavin, 2006; Jacob and Castanedo-Tardan, 2007].
  • The frequent or prolonged use of systemic corticosteroids is associated with serious adverse effects, including growth retardation in children, diabetes mellitus, high blood pressure, and osteoporosis. However, these are unlikely to be a problem with a single, short course of prednisolone. Consider referral:
    • If more than very occasional use is needed (e.g. more than one course in a year).
    • For children younger than 16 years of age.
  • Do not prescribe an oral corticosteroid if continued exposure to the allergen cannot be avoided.

© NHS Institute for Innovation and Improvement